The discovery of genetic mapping led to a considerable expansion of medical data knowledge or ‘big data,’ which Foley partner Richard Kaufman suggests can be properly analyzed to improve drug discovery success and reduce the cost of developing a drug. He compares genetic mapping to an exquisite tailoring of one’s personal biology that holds the potential to make drugs developed using this data much more effective and ultimately may lead to better outcomes for patients.
People
Related News
18 April 2024
In the News
Lynn Gandhi Unravels Tax Challenges in Hybrid Work Environments
Foley & Lardner LLP partner Lynn Gandhi offers insights on the taxation challenges a hybrid work environment can pose for human resources and payroll in the Reuters article "Tax attorney: Navigating the nuances of taxation in hybrid work arrangements.”
17 April 2024
In the News
Steven Barth on Allure of Take-Private Deals – 'Public markets aren’t what they’re cracked up to be'
Foley & Lardner LLP partner Steven Barth offers extensive insight on the growing trend of family-owned consumer and retail businesses aiming to go private in the Axios article, “Family-owned companies see allure in take-private deals.”
17 April 2024
In the News
Christopher Ward on Federal Arbitration Act – ‘It matters what a worker does’
Foley & Lardner LLP partner Christopher Ward is quoted in the Law360 article, “Airplane Servicers Nod to Justices, Reiterate That Fueling Isn't Interstate Work.”